Form 8-K - Current report:
SEC Accession No. 0001493152-24-036888
Filing Date
2024-09-17
Accepted
2024-09-17 17:18:29
Documents
71
Period of Report
2024-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46792
2 ex1-1.htm EX-1.1 44483
3 ex99-1.htm EX-99.1 9427
4 ex99-2.htm EX-99.2 11051
5 ex1-1_001.jpg GRAPHIC 410646
6 ex1-1_002.jpg GRAPHIC 428122
7 ex1-1_003.jpg GRAPHIC 541302
8 ex1-1_004.jpg GRAPHIC 610706
9 ex1-1_005.jpg GRAPHIC 566900
10 ex1-1_006.jpg GRAPHIC 538858
11 ex1-1_007.jpg GRAPHIC 579858
12 ex1-1_008.jpg GRAPHIC 606167
13 ex1-1_009.jpg GRAPHIC 591058
14 ex1-1_010.jpg GRAPHIC 558056
15 ex1-1_011.jpg GRAPHIC 482280
16 ex1-1_012.jpg GRAPHIC 442180
17 ex1-1_013.jpg GRAPHIC 438578
18 ex1-1_014.jpg GRAPHIC 435934
19 ex1-1_015.jpg GRAPHIC 507971
20 ex1-1_016.jpg GRAPHIC 506467
21 ex1-1_017.jpg GRAPHIC 534663
22 ex1-1_018.jpg GRAPHIC 536140
23 ex1-1_019.jpg GRAPHIC 520782
24 ex1-1_020.jpg GRAPHIC 476309
25 ex1-1_021.jpg GRAPHIC 641846
26 ex1-1_022.jpg GRAPHIC 607585
27 ex1-1_023.jpg GRAPHIC 576102
28 ex1-1_024.jpg GRAPHIC 346144
29 ex1-1_025.jpg GRAPHIC 464678
30 ex1-1_026.jpg GRAPHIC 490228
31 ex1-1_027.jpg GRAPHIC 343715
32 ex1-1_028.jpg GRAPHIC 418922
33 ex1-1_029.jpg GRAPHIC 196241
34 ex1-1_030.jpg GRAPHIC 81301
35 ex1-1_031.jpg GRAPHIC 66334
36 ex1-1_032.jpg GRAPHIC 46274
37 ex1-1_033.jpg GRAPHIC 69901
38 ex1-1_034.jpg GRAPHIC 76702
39 ex1-1_035.jpg GRAPHIC 53833
40 ex1-1_036.jpg GRAPHIC 480526
41 ex1-1_037.jpg GRAPHIC 594323
42 ex1-1_038.jpg GRAPHIC 165107
43 ex1-1_039.jpg GRAPHIC 107934
44 ex1-1_040.jpg GRAPHIC 117865
45 ex1-1_041.jpg GRAPHIC 257464
46 ex1-1_042.jpg GRAPHIC 492635
47 ex1-1_043.jpg GRAPHIC 555416
48 ex1-1_044.jpg GRAPHIC 633258
49 ex1-1_045.jpg GRAPHIC 641139
50 ex1-1_046.jpg GRAPHIC 534841
51 ex1-1_047.jpg GRAPHIC 639953
52 ex1-1_048.jpg GRAPHIC 449099
53 ex1-1_049.jpg GRAPHIC 476338
54 ex1-1_050.jpg GRAPHIC 175336
55 ex1-1_051.jpg GRAPHIC 36633
56 ex1-1_052.jpg GRAPHIC 259220
57 ex1-1_053.jpg GRAPHIC 115989
58 ex99-1_001.jpg GRAPHIC 36178
59 ex99-2_001.jpg GRAPHIC 22367
  Complete submission text file 0001493152-24-036888.txt   30025950

Data Files

Seq Description Document Type Size
60 XBRL SCHEMA FILE ibo-20240916.xsd EX-101.SCH 3033
61 XBRL LABEL FILE ibo-20240916_lab.xml EX-101.LAB 34240
62 XBRL PRESENTATION FILE ibo-20240916_pre.xml EX-101.PRE 24178
73 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3494
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42212 | Film No.: 241305371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)